1. Home
  2. GETY vs CRBP Comparison

GETY vs CRBP Comparison

Compare GETY & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Images Holdings Inc.

GETY

Getty Images Holdings Inc.

HOLD

Current Price

$0.26

Market Cap

183.0M

Sector

Industrials

ML Signal

HOLD

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$10.38

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GETY
CRBP
Founded
1995
2009
Country
United States
United States
Employees
N/A
36
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
183.0M
190.3M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
GETY
CRBP
Price
$0.26
$10.38
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$3.78
$45.50
AVG Volume (30 Days)
4.2M
343.4K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$926,244,000.00
$4,822,272.00
Revenue This Year
$0.37
N/A
Revenue Next Year
$1.47
$116.00
P/E Ratio
N/A
N/A
Revenue Growth
0.82
97.62
52 Week Low
$0.26
$7.12
52 Week High
$3.21
$20.56

Technical Indicators

Market Signals
Indicator
GETY
CRBP
Relative Strength Index (RSI) 28.93 59.38
Support Level N/A $8.30
Resistance Level $0.51 $10.74
Average True Range (ATR) 0.04 0.54
MACD 0.00 0.03
Stochastic Oscillator 1.02 68.27

Price Performance

Historical Comparison
GETY
CRBP

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: